Positioned as a critical biomarker assay for autoimmune research, the blood test cyclic citrullinated peptide (anti-CCP) serves as a high-specificity tool for laboratory diagnostics. This guide details purity specifications exceeding 98% via HPLC, ensuring minimal cross-reactivity in serological studies. Manufacturing adheres to cGMP standards with synthetic peptide sequences validated for consistent lot-to-lot performance. Key applications include clinical trial cohort screening and autoimmune biomarker validation. Quality advantages feature rigorous endotoxin control and lyophilized stability for extended shelf life. Buyer pain points addressed include batch variability, false-positive risks, and sourcing from non-certified facilities. By prioritizing traceable raw materials and ISO-compliant production, this guide helps procurement teams secure reliable anti-CCP reagents for reproducible research outcomes.
Target Keyword: blood test cyclic citrullinated peptide
The blood test cyclic citrullinated peptide (anti-CCP) is a critical biomarker peptide used extensively in autoimmune diagnostics and laboratory research. This synthetic peptide, derived from citrullinated protein sequences, enables highly specific detection of autoantibodies associated with rheumatoid arthritis. For B2B buyers—including diagnostic kit manufacturers, clinical laboratories, cosmetic R&D departments, and bulk peptide distributors—the purity, stability, and manufacturing consistency of this peptide directly impact assay reliability and commercial value. This guide provides comprehensive specifications, sourcing criteria, and quality benchmarks to support informed procurement decisions.
The blood test cyclic citrullinated peptide is a cyclic peptide containing citrulline residues, typically synthesized via solid-phase peptide synthesis (SPPS). Its molecular structure ensures high affinity for anti-CCP antibodies, making it indispensable for ELISA and chemiluminescence immunoassays.
Industry data indicates that peptide purity below 95% can reduce anti-CCP assay specificity by up to 12%, leading to false-positive rates in clinical diagnostics. Reliable sourcing of ≥98% pure cyclic citrullinated peptide is therefore non-negotiable for regulatory compliance.
Production of the blood test cyclic citrullinated peptide follows a rigorous multi-step process to ensure batch-to-batch consistency and high immunoreactivity.
The blood test cyclic citrullinated peptide serves diverse B2B applications, each requiring specific purity and formulation considerations.
In anti-aging and skin barrier products, cyclic citrullinated peptides are used as active ingredients to support collagen synthesis and reduce inflammation. For cosmetic use, purity ≥95% is acceptable, with added stabilizers (e.g., trehalose) to enhance shelf life. Bulk orders typically range from 10 g to 100 g per batch.
Academic and pharmaceutical labs require ultra-pure (≥98%) peptide for antibody development, assay validation, and epitope mapping. Small-scale orders (1 mg–1 g) are common, with lyophilized aliquots to minimize freeze-thaw cycles.
Diagnostic kit manufacturers purchase in bulk (100 g–10 kg) for large-scale ELISA production. Here, consistent immunoreactivity and low endotoxin levels (<0.5 EU/mg) are critical. Custom cyclization and sequence modifications (e.g., biotinylation) are often requested.
| Item | Our Product | Alternatives | Advantages |
|---|---|---|---|
| Purity | ≥98% by HPLC | 85–92% by HPLC | Higher specificity, lower false positives |
| Cyclization Efficiency | >95% disulfide bond formation | 70–80% cyclization | Consistent antibody binding |
| Endotoxin Level | <0.5 EU/mg | 1–5 EU/mg | Safe for in vitro diagnostics |
| Batch Consistency | CV <3% across batches | CV 8–15% | Reliable assay performance |
When sourcing blood test cyclic citrullinated peptide in bulk, avoid common pitfalls by following these standards.
Our blood test cyclic citrullinated peptide offers unmatched purity, stability, and cost performance for B2B buyers.
Q1: What is the minimum purity required for blood test cyclic citrullinated peptide in diagnostic kits?
For diagnostic ELISA kits, purity must be ≥98% by HPLC to ensure specificity above 95%. Lower purity can lead to false positives and regulatory non-compliance.
Q2: How do you verify the cyclization of cyclic citrullinated peptide?
Cyclization is confirmed by HPLC retention time shift (cyclic vs. linear), mass spectrometry (molecular weight reduction of 2 Da per disulfide bond), and Ellman’s test for free thiol groups.
Q3: Can you provide custom sequences or modifications for bulk orders?
Yes, we offer custom synthesis including biotinylation, fluorescent labeling, and sequence optimization for specific assay requirements. Minimum order for custom peptides is 100 mg.